MedTrace Logo

Home-Based Exergame Motor-Cognitive Rehabilitation for Traumatic Brain Injury

NCT07733336 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-08-11

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness of a home-based cognitive-motor telerehabilitation program in individuals with traumatic brain injury (TBI) following discharge from intensive inpatient neurorehabilitation.

The main questions it aims to answer are:

* Does home-based cognitive-motor telerehabilitation improve functional independence, cognitive performance, mobility, and quality of life in individuals with TBI?
* Are the effects of home-based cognitive-motor telerehabilitation superior to those achieved with standard outpatient rehabilitation?

The study will compare a home-based cognitive-motor telerehabilitation program with standard outpatient rehabilitation to determine their relative effects on functional recovery.

Participants will:

* Receive either home-based cognitive-motor telerehabilitation or standard outpatient rehabilitation, according to the assigned treatment pathway. Both rehabilitation programs consist of 20 sessions lasting 45 minutes each, three times per week.
* Undergo clinical, cognitive, and motor assessments at predefined study time points: T0 (hospital discharge, pre-intervention), T1 (post-intervention, 7 weeks after T0), and T2 (follow-up, 6 months after T0).
* Be evaluated for changes in functional independence, cognitive functioning, mobility, quality of life, and caregiver burden.

Conditions

Interventions

OTHER

HOME-EXER telerehabilitation protocol

Participants will follow the HOME-EXER telerehabilitation protocol

OTHER

OUT-REHAB rehabilitation protocol

Participants will follow the OUT-REHAB rehabilitation protocol

Sponsors & Collaborators

  • Istituto Auxologico Italiano

    collaborator OTHER

  • Fondazione Don Carlo Gnocchi ETS

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-11-03
Primary Completion
2029-03-31
Completion
2029-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07733336 on ClinicalTrials.gov